Pfizer coming into a triple bottom, and oversold on the RSI and MACD. If the bird flu (AKA H5N1) story gets bigger Pfizer could see a nice influx of money that may just follow the story.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
